Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment More
SAN DIEGO, Calif., Oct. 27, 2015 -- Agena Bioscience announced today the planned commercial launch of its CE-IVD marked MassARRAY®...
Agena Bioscience to Present Enabling Solutions for Molecular Blood Group Genotyping at AABB 2015 More
SAN DIEGO, Calif., Oct. 20, 2015 -- Agena Bioscience™ today announced expanded use of its MassARRAY® System...
Agena Bioscience Opens Office in Shanghai, China More
SAN DIEGO, Calif., Sep. 1, 2015 -- Agena Bioscience today announced the establishment of a subsidiary in Shanghai, a commercial...
Agena Bioscience Introduces Front-End Automation for Its MassARRAY® System for Genetic Analysis More
New Chip Prep Module Streamlines Workflow and Reduces Hands-On Time for Laboratories Implementing Genetic TestingSAN DIEGO,...
Agena Bioscience European Distributors Expand to KAWA.SKA and BioGen-Analytica 更多
SAN DIEGO, Calif., Jun. 11, 2015 -- Agena Bioscience today expanded its European distributors through new relationships with...
Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China More
SAN DIEGO, Calif., Apr. 27, 2015 -- Agena Bioscience today announced Bioyong Technology as the fifth certified service provider...
Agena Bioscience Launches LungFUSION™ Panel for Rapid Identification of ALK, RET, and ROS1 Translocations in NSCLC Tumors More
SAN DIEGO, March 25, 2015 /PRNewswire/ -- Agena Bioscience today released the LungFUSION Panel for rapid and sensitive identification...
Agena Bioscience Launches MassARRAY® 24-Well System for Affordable Genetic Testing, Liquid Biopsies More
SAN DIEGO, Calif., Feb. 24, 2015 -- Agena Bioscience today released the MassARRAY® 24-Well System for mass spectrometry-based...
Agena Bioscience Appoints Peter Dansky as Chief Executive Officer More
Life science industry executive to guide expansion of MassARRAY® platform into the clinical research and diagnostics...
Agena Bioscience Announces FDA 510(K) Premarket Clearance of the IMPACT Dx™ Factor V Leiden and Factor II Genotyping Test on the IMPACT Dx™ System More
IMPACT Dx™ Combined Function System Will Also Be Available in the European UnionSan Diego, Calif., June 16,...
Agena Bioscience Introduces the Hemo ID™ Panel for Blood Group Genotyping at the 33rd International Congress of the ISBT in Seoul, Korea More
Swiss Red Cross Study Recommends Replacing Kell, Kidd, Duffy Serotyping with GenotypingSan Diego, Calif., June 4, 2014/PRNewswire/...
Sequenom, Inc.’s Bioscience Business Acquired by Agena Bioscience, a Telegraph Hill Partners Portfolio Company More
John Lillig to Lead Agena Bioscience as Chairman and Interim CEOSan Diego, Calif. – May 30, 2014 – Agena Bioscience,...